Where does Cardiovalve Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cardiovalve Ltd. ranks #3,153 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cardiovalve Ltd. hold?

Cardiovalve Ltd. holds 119 US utility patents granted between 2018 and 2025, spanning 16 technology areas.

What is Cardiovalve Ltd.'s Innovation Score?

Cardiovalve Ltd. has an Innovation Score of 50.0 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cardiovalve Ltd.'s patent grant rate increasing or decreasing?

Cardiovalve Ltd.'s recent grant velocity is +395% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cardiovalve Ltd.'s patents?

Cardiovalve Ltd.'s patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cardiovalve Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cardiovalve Ltd.

Q: What technology areas does Cardiovalve Ltd. focus on?

Cardiovalve Ltd.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 117 patents, ranking #43 of 3,082 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 119 granted patents across 16 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cardiovalve ranks #3,153 of 49,997 tracked US assignees by granted-patent volume, with 119 patents across 16 technology areas.

#3,153
of 49,997 US assignees by volume: Top 14%
by Innovation Score (50.0/100): 21.4
avg claims per patent: +395%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3153 · Foreign Corporation #3,153 · 119 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 119 grants
TOP-DECILE #3,153/49,997
PHOTO-FINISH Adva Optical…
CPC-FOCUS A61F · 16 areas
INNOV-PAR 50.0/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +395% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adva Optical Networking SE (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cardiovalve’s 50.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.5 pts (33%) Velocity 6.5 pts (13%) Breadth 14.1 pts (28%) Claim depth 12.8 pts (26%)

Qualcomm Incorporated · highest

85
Cardiovalve · this assignee

50
Centripetal Networks · near

50
Kymab · near

50
National Products · near

50
REIFENHÄUSER & KG… · near

50
3D Lighting… · lowest

7

What this shows Cardiovalve's Innovation Score is 50.0/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cardiovalve?

Each dot is one of Cardiovalve’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cardiovalve’s own 21.4 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cardiovalve vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cardiovalve's grants concentrate

Cardiovalve Ltd. is a focused PatentsView assignee: 16 CPC subclasses with 98.3% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (25 grants) versus a trough of 2 in 2018. By volume, Cardiovalve sits between Adva Optical Networking SE and Icom Incorporated.

Cardiovalve's three-year grant acceleration

From 2019–2021 to 2022–2024, Cardiovalve Ltd. moved from 56 to 55 grants (0.98x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,229. See the growth leaderboard.

Adva Optical Netw…

119
Advanced Optoelec…

119
Ambit Microsystem…

119
ATI Properties

119
Centripetal Netwo…

119
Corning Optical C…

119
Driscoll's

119
Icom Incorporated

119
Cardiovalve ◀

119

What this shows Cardiovalve holds 119 patents at rank #3,153, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cardiovalve

By rank, the assignees closest to #3,153 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Cardiovalve's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cardiovalve, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Cardiovalve ranks #43 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Centripetal Networks, LLC 50 Kymab Limited 50 REIFENHÄUSER GMBH & Co. KG Maschinenfabrik 50 National Products, Inc. 50

Similar claim depth

Nearest assignees by average claims per patent (21.4 here).

FCI USA LLC 21.4 avg TiVo Solutions Inc. 21.4 avg ecoATM, LLC 21.4 avg Box, Inc. 21.4 avg

Cardiovalve's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Cardiovalve Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	1.7%
2019	17	14.3%
2020	25	21.0%
2021	14	11.8%
2022	22	18.5%
2023	15	12.6%
2024	18	15.1%
2025partial year	6	5.0%

Which technologies does Cardiovalve Ltd. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 117

A61B - DIAGNOSIS; SURGERY; Identification 22

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 4

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 4

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 3

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 3

H04N - Pictorial Communication, e.g. Television 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 2

Y10T - Technical Subjects Covered BY Former US Classification 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

B26D - CUTTING; Details Common TO Machines FOR Perforating, Punching, Cutting-out, Stamping-out OR Severing 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cardiovalve Ltd.'s patent record in context - here's where to go next.

Cardiovalve Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 98.3% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #3,153 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cardiovalve Ltd. against Adva Optical Networking SE, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.